- Preclinical and clinical development of pegylated interferon-lambda 1 in chronic hepatitis CEleanor L Ramos
ZymoGenetics, Inc, Seattle, Washington 98101, USA
J Interferon Cytokine Res 30:591-5. 2010..Constitutional symptoms appeared lower than historical data for PEG-IFN-alpha. These results form the basis of further development of pegIFNlambda as a novel treatment for chronic hepatitis C...